Pramila Krishnamurthy
@drpramilak
Consultant in haematology, King’s College Hospital, London. AML, MDS and BMT. John Goldman Leukaemia UK Fellow 2021
ID: 79290077
02-10-2009 21:19:40
1,1K Tweet
1,1K Followers
1,1K Following
Say Hello to ATICUS! Supported by our patron Gary Lineker, this network funds potentially life-saving trials for children with blood cancer across 11 UK hospitals. This network costs £1M to fund, that's why we're calling on businesses to join Club 10: cureleukaemia.co.uk/community-blog…
Weekly selection of papers in myeloid leukemia is out. Very long this week so get ready! Thanks as always Bims: Biomed News biomed.news/bims-tremyl/20…
Dr David Lewis 🇬🇧 presenting primary outcome data from the ENRICH RCT. Huge effort & important data Toby Eyre Mark Bishton Simon Rule
CONGRESS | #ASH24 | POSTER Pramila Krishnamurthy, King's College NHS, presents a retrospective observational study on treatment patterns and clinical outcomes with oral azacitidine maintenance therapy in real-world patients with AML in Germany (n=106) and England (n=107). Median OS and rwRFS
Ending #ASH24 Sunday with a spectacular presentation on Black AML, highlighting the role of PHIP mutations in this pt population by AK Eisfeld and moderated by Jennifer Trowbridge Read their beautiful paper in Nature Genetics here nature.com/articles/s4158… Lee Grimes Lab Bailee Kain
Fantastic talk from Dr. Zheng from the Myeloid Leukaemia Genomics and Biology Group on the role of TP53 mutations in CH-associated dyserythropoiesis and OxPhos alterations!
➡️ Check out our paper on Clinical interrogation of TP53 aberrations and its impact on survival in patients with myeloid neoplasms Haematologica haematologica.org/haematologica/… ✅ A clinically relevant and easy to use TP53 aberration burden stratification and a closer look at outcomes
1/6 🧵 Now out in Blood Cancer Discovery. Comprehensive study (n=263) on immune reconstitution (IR) after CD19-#CART (axi/liso/tisa-cel) in LBCL. Led by the talented Danny Luan. #Lymphoma #Tcells #NKcells Memorial Sloan Kettering Cancer Center doi.org/10.1158/2643-3…
Thrilled to share a wonderful collaboration with Scott Armstrong Florian Perner Shellaina Gordon !! Catalytic inhibition of KAT6/KAT7 enhances the efficacy and overcomes primary and acquired resistance to Menin inhibitors in MLL leukaemia biorxiv.org/content/10.110…
👉👉👉Delighted to share our group’s new paper analyzing #TP53 impact & outcomes in patients with myeloid neoplasms 🚨 just out in Haematologica led by Dr Jayastu Senapati , Dr Sanam Loghavi, MD صنم لغوی 🔬🧬 & Dr Naval Daver, M.D. #leusm #endcancer haematologica.org/article/view/1…
Thank you Cure Leukaemia James McLaughlin for your relentless focus & commitment on improving survival for patients with blood cancer via innovative clinical trials Charlie Craddock CBE Pramila Krishnamurthy #ProfSteveKnapper #TAPnetwork Accelerating Clinical Trials Paul Sherrington Katherine Holes @manicmum35
Our most recent review in Blood .. honored to work on this with the talented Alain Mina who put this together ashpublications.org/blood/article-…
Preprint alert: this was a wonderful collaborative project with Prof Karadimitris Imperial Department of Immunology & Inflammation and many others. Thanks to all and especially Science and Innovation at Cancer Research UK for the CAYP innovation award funding. All feedback welcome! biorxiv.org/content/10.110…
🔴 We strongly welcome the Public Accounts Committee Report on Remediation of Dangerous Cladding. We thank the Public Accounts Committee Chair & members for shining a light on the Govt's failure to tackle this crisis. Our statement 👇 Angela Rayner Alex Norris MP endourcladdingscandal.org/posts/our-stat…
Today, Kerry McNally Group Head of Communities at Flutter Entertainment visited King's College NHS to learn how their funding over the past three years and their continued support have directly impacted blood cancer patients across the UK and contributed to a wider global impact.
